MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1515/cclm-2021-0504

Медицинская библиотека · Clinical chemistry and laboratory medicine · 2021

Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.

Klotz Daniel Martin, Link Theresa, Goeckenjan Maren, Wimberger Pauline, Poetsch Anna R, Jaschke Nikolai, Hofbauer Lorenz C, Göbel Andy, Rachner Tilman D, Kuhlmann Jan Dominik

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Dickkopf-1 (DKK1) is a secreted protein, known for suppressing the differentiation and activity of bone-building osteoblasts by acting as an inhibitor of Wnt-signalling. Soluble DKK1 (sDKK1) has been proposed as prognostic biomarker for a wide range of malignancies, however, clinical relevance of sDKK1 as potential blood-based marker for ovarian cancer is unknown.

METHODS

sDKK1 levels were quantified in a cohort of 150 clinically documented ovarian cancer patients by a commercially available DKK1 ELISA (Biomedica, Vienna, Austria).

RESULTS

Median sDKK1 level was significantly elevated at primary diagnosis of ovarian cancer compared to healthy controls (estimated difference (ED) of 7.75 ng/mL (95% CI: 3.01-12.30 ng/mL, p=0.001)). Higher levels of sDKK1 at diagnosis indicated an increased volume of intraoperative malignant ascites (ED 7.08 pmol/L, 95% CI: 1.46-13.05, p=0.02) and predicted suboptimal debulking surgery (ED 6.88 pmol/L, 95% CI: 1.73-11.87, p=0.01). sDKK1 did not correlate with CA125 and higher sDKK1 levels predicted a higher risk of recurrence and poor survival (PFS: HR=0.507, 95% CI: 0.317-0.809; p=0.004; OS: HR=0.561, 95% CI: 0.320-0.986; p=0.044). Prognostic relevance of sDKK1 was partly sustained in wtBRCA patients (PFS: HR=0.507, 95% CI: 0.317-0.809; p=0.004).

CONCLUSIONS

This is the first study demonstrating the prognostic relevance of sDKK1 in ovarian cancer patients, including those with wtBRCA1/2 status. Our data encourage further evaluation of sDKK1 in ovarian cancer patients, possibly in terms of a therapy monitoring marker or a response predictor for sDKK1-directed targeted therapies.

Для цитирования: Klotz Daniel Martin, Link Theresa, Goeckenjan Maren, Wimberger Pauline, Poetsch Anna R, Jaschke Nikolai, Hofbauer Lorenz C, Göbel Andy, Rachner Tilman D, Kuhlmann Jan Dominik. Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.. Clinical chemistry and laboratory medicine. 2021. DOI: 10.1515/cclm-2021-0504.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.